Search results for "PASS"

showing 10 items of 1629 documents

The COMPASS experiment at CERN

2007

The COMPASS experiment makes use of the CERN SPS high-intensitymuon and hadron beams for the investigation of the nucleon spin structure and the spectroscopy of hadrons. One or more outgoing particles are detected in coincidence with the incoming muon or hadron. A large polarized target inside a superconducting solenoid is used for the measurements with the muon beam. Outgoing particles are detected by a two-stage, large angle and large momentum range spectrometer. The setup is built using several types of tracking detectors, according to the expected incident rate, required space resolution and the solid angle to be covered. Particle identification is achieved using a RICH counter and both…

Nuclear and High Energy Physicsstraw tube detectorPhysics::Instrumentation and DetectorsProject commissioningFOS: Physical sciencesfixed-target experimentRICH detectorhadron structureHigh Energy Physics - ExperimenttargetMWPCNuclear physicsHigh Energy Physics - Experiment (hep-ex)CompassHadron spectroscopyCOMPASS experimentscintillating fibre detectorNuclear Experimentsilicon microstrip detectorsInstrumentationSilicon microstrip detectorsPhysicsLarge Hadron ColliderStructure functionMicroMegas detectorfront-end electronicsDAQmicromegas detectordrift chamberPhysics::Accelerator PhysicsHigh Energy Physics::ExperimentpolarisedGEM detectorcalorimetryParticle Physics - Experimentpolarised DISNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
researchProduct

Prospects for a DVCS measurement at COMPASS

2010

The high energy polarised muon beam available at CERN with the option of using positive or negative muons with opposite polarisation gives COMPASS an excellent possibility to study generalised parton distributions via deeply virtual Compton scattering. In a first step we propose to use an unpolarised proton target to study the slope of the t dependence of the differential cross section as a function of xB j to observe a possible shrinkage of the nucleon with increasing xB j. Furthermore, the beam charge and spin difference will be measured over a wide kinematical range to determine the Compton form factor related to the GPD H. As a second step we consider to use a transversely polarised pro…

Nuclear physicsPhysicsLarge Hadron ColliderMuonProtonCompassForm factor (quantum field theory)Compton scatteringPartonNuclear ExperimentNucleonProceedings of XVIII International Workshop on Deep-Inelastic Scattering and Related Subjects — PoS(DIS 2010)
researchProduct

An elliptic equation on n-dimensional manifolds

2020

We consider an elliptic equation driven by a p-Laplacian-like operator, on an n-dimensional Riemannian manifold. The growth condition on the right-hand side of the equation depends on the geometry of the manifold. We produce a nontrivial solution by using a Palais–Smale compactness condition and a mountain pass geometry.

Numerical AnalysisPure mathematicsN dimensionalApplied MathematicsOperator (physics)p-Laplacian-like operator010102 general mathematicsIsocapacitary inequalityRiemannian manifoldSobolev space01 natural sciences010101 applied mathematicsSobolev spaceComputational MathematicsElliptic curvemountain pass geometrySettore MAT/05 - Analisi MatematicaMathematics::Differential Geometry0101 mathematicsOrlicz spaceAnalysisMathematicsComplex Variables and Elliptic Equations
researchProduct

Mindfulness, empatía y compasión: Evolución de la empatía a la compasión en el ámbito sanitario

2019

En el ámbito de la atención a la salud mental, la empatía es un aspecto especialmente importante, ya que supone la base sobre la que se sostiene elvínculo terapéutico y se articulan las diferentes actuaciones psicológicas, al facilitar un entendimiento de la vida y de las situaciones de los pacientes. En este sentido, las intervenciones basadas en mindfulness y compasión (IBMC) se han mostrado efectivas para aumentar la empatía en los profesionales sanitarios. Sin embargo, actualmente siguen existiendo algunas inconsistencias en el estudio de la empatía y su relación con mindfulness y compasión. En este artículo, se expone una visión global de estos constructos, subrayando la importancia de…

NurseryMedicinaSesgos en la InferenciaClinical and Health PsychologyGeneral MedicineCompasiónPsicología Clínica y de la SaludPsychotherapyPsicoterapiaCompassionMedicineEnfermeríaBiases in the InferenceEmpathyMindfulnessPhysical therapyEmpatíaFisioterapiaDeportesSportsRevista de Investigación y Educación en Ciencias de la Salud (RIECS)
researchProduct

Prevalence of tick-borne pathogens in ticks collected from migratory birds in Latvia.

2014

Migratory birds act as hosts and long-distance vectors for several tick-borne infectious agents. Here, feeding Ixodes ticks were collected from migratory birds during the autumn migration period in Latvia and screened for the presence of epidemiologically important non-viral pathogens. A total of 93 DNA samples of ticks (37 larvae and 56 nymphs) removed from 41 birds (order Passeriformes, 9 species) was tested for Lyme borreliosis spirochaetes, Anaplasma phagocytophilum, Rickettsia spp., and Babesia spp. Borrelia burgdorferi DNA was detected in 18% of the tick samples, and a majority of infected ticks were from thrush (Turdus spp.) birds. Among the infected ticks, Borrelia valaisiana was de…

NymphBorrelia valaisianaanimal diseasesMolecular Sequence DataZoologyBabesiaTickmedicine.disease_causeMicrobiologyMicrobiologyBorreliaparasitic diseasesmedicinePrevalenceAnimalsPasseriformesRickettsiaPhylogenybiologyBase SequenceIxodesBorreliaSequence Analysis DNAbacterial infections and mycosesbiology.organism_classificationAnaplasma phagocytophilumLatviaInfectious DiseasesRickettsiaTick-Borne DiseasesInsect ScienceLarvaBabesiaParasitologyBorrelia gariniiIxodesArachnid VectorsAnaplasma phagocytophilumTicks and tick-borne diseases
researchProduct

MUSIC-based modal channel estimation for wideband OFDM-OQAM

2008

Orthogonal frequency division multiplexing based on offset quadrature amplitude modulation (OFDM-OQAM) over wideband frequency selective multipath channels suffers from inter-symbol interference (ISI) and inter-carrier interference (ICI) that degrade its performance. Channel estimation and equalization are needed to combat these interferences. In this paper a novel channel estimator for passband OFDM-OQAM signaling over wideband multipath channels, which is based on multiple signal classification (MUSIC) with the Spatial Smoothing technique is presented. Numerical simulation results are presented in the low number of subcarriers, i.e. wideband, scenario.

OFDM-OQAMSettore ING-INF/03 - TelecomunicazioniOrthogonal frequency-division multiplexingComputer sciencebusiness.industryChannel estimationMUSICComputer Science::OtherIntersymbol interferenceInterference (communication)Computer Science::Networking and Internet ArchitectureElectronic engineeringWidebandTelecommunicationsbusinessPassbandQuadrature amplitude modulationSmoothingComputer Science::Information TheoryCommunication channel2008 1st IFIP Wireless Days
researchProduct

Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.

2010

Up to 10% of germ cell tumor patients require salvage high-dose chemotherapy with stem cell support, achieving cure rates in the range of 10-60%. Stem cell mobilization may be difficult in these patients because of multiple lines of treatment known to seriously hamper stem cell recovery. Plerixafor significantly enhances the success of the CD34+ cell harvest, even in cases where prior mobilization attempts have failed. Six germ cell tumor patients provided informed consent and were included in the compassionate use program. All patients were heavily pretreated, with a median of 3.5 prior lines of therapy. All failed prior mobilization with G-CSF in combination with chemotherapy. Five patien…

OncologyAdultCompassionate Use TrialsMalemedicine.medical_specialtyBenzylaminesPlatelet Engraftmentmedicine.medical_treatmentCD34Hematopoietic stem cell transplantationCyclamsYoung AdultTesticular NeoplasmsHeterocyclic CompoundsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansUltrasonographyTransplantationChemotherapyMobilizationbusiness.industryPlerixaforHematopoietic Stem Cell TransplantationHematologyMiddle AgedNeoplasms Germ Cell and EmbryonalCombined Modality TherapyHematopoietic Stem Cell MobilizationSurgerySeminomamedicine.anatomical_structureStem cellbusinessGerm cellmedicine.drugBone marrow transplantation
researchProduct

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for…

2018

IntroductionRoux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups.Methods and analysisThis open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability…

OncologyMale030226 pharmacology & pharmacylaw.inventionTertiary Care Centers0302 clinical medicineWeight losslawRisk FactorsProtocol1506Omeprazolemedia_commonClinical Trials as TopicClinical pharmacologyNorwayArea under the curveGeneral MedicineObesity MorbidPharmaceutical PreparationsCardiovascular DiseasescardiologyBody CompositionFemalemedicine.symptommedicine.drugDrugmedicine.medical_specialtymedia_common.quotation_subjectGastric Bypassbasic sciencesBiological Availability030209 endocrinology & metabolism03 medical and health sciencesPharmacokineticsInternal medicineWeight LossmedicineHumansRosuvastatinPharmacokinetics1723Caloric Restrictionbusiness.industryPharmacology and TherapeuticsBioavailabilityLinear Modelsclinical pharmacologybusinessBiomarkers
researchProduct

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community…

2011

Background The European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study provided sorafenib to advanced renal cell carcinoma (RCC) patients in whom previous systemic therapy had failed. The study assessed the safety and use of sorafenib for the treatment of advanced RCC in a large community-based patient population across 11 countries in Europe. Patients and methods EU-ARCCS was a single-arm, open-label trial of sorafenib in advanced RCC patients. End points included safety, time to progression, progression-free survival (PFS), and disease control rate (DCR). Subgroup analyses included age, Eastern Cooperative Oncology Group performance status, histology, prior thera…

OncologySorafenibAdultCompassionate Use TrialsMaleNiacinamidemedicine.medical_specialtyAdolescentPyridinesPopulationAntineoplastic Agentsurologic and male genital diseasesDisease-Free SurvivalRenal cell carcinomaInternal medicinemedicineCarcinomaHumanseducationCarcinoma Renal CellneoplasmsAgedNeoplasm StagingAged 80 and overeducation.field_of_studybusiness.industryPhenylurea CompoundsBenzenesulfonatesAge FactorsHematologyMiddle AgedSorafenibmedicine.diseaseRashKidney Neoplasmsfemale genital diseases and pregnancy complicationsSurgeryClinical trialEuropeTreatment OutcomeOncologyTolerabilityExpanded accessFemalemedicine.symptombusinessmedicine.drug
researchProduct

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (…

2020

Introduction The antibody-drug conjugate polatuzumab vedotin (Pola) has recently been approved in combination with bendamustine and rituximab (Pola-BR) for patients with r/r diffuse LBCL (DLBCL). Methods To characterize the efficacy of Pola-BR in a real-world setting, we retrospectively analyzed data from 97 patients with r/r LBCL who were treated with Pola in 24 German centers within the national CUP. Clinical baseline and follow-up (FU) data were collected by chart review and summarized descriptively. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier and Cox regression methods. Fisher's exact test was used to compare categorical factors between gro…

Oncologymedicine.medical_specialtybusiness.industryImmunologyCompassionate UseCell BiologyHematologymedicine.diseaseBiochemistrylanguage.human_languagePolatuzumab vedotinGermanRefractoryInternal medicinemedicinelanguagebusinessB-cell lymphomaReal world dataBlood
researchProduct